Biopool International Inc. and Xtrana have entered into an agreement to merge.
The transaction is valued at $10 million.
Biopool, based in Ventura, develops in vitro technology that can detect anything from medical disorders to drug use in a patient's blood. Its product, SURE-Urine, is used to detect drug levels in a patient...
The transaction is valued at $10 million.
Biopool, based in Ventura, develops in vitro technology that can detect anything from medical disorders to drug use in a patient's blood. Its product, SURE-Urine, is used to detect drug levels in a patient...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In